期刊
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
卷 26, 期 11, 页码 2603-2614出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jstrokecerebrovasdis.2017.06.023
关键词
Permanent cerebral ischemia; STVNa; NF-kappa B; inflammatory; apoptosis
资金
- Science and Technology Planning Project of Guangdong Province [2015B010109004]
- National Natural Science Foundation of China [31601089]
- Fundamental Research Funds for the Central Universities [2015ZM177]
- Open Project Program of Guangdong Key Laboratory of Fermentation and Enzyme Engineering, SCUT [FJ2015009]
Background: Isosteviol sodium (STVNa) has been reported to have neuroprotective effects against ischemia/reperfusion (I/R) injury in rats. Furthermore, recanalization treatments, including thrombolytic therapy, have several limitations. Excessive inflammation and apoptosis contribute to the pathogenesis of ischemic brain damage. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) is critical to these processes and is associated with cerebral ischemia. Therefore, we studied the potential therapeutic effects and mechanisms of STVNa on permanent cerebral ischemia in mice. Methods: Permanent middle cerebral artery occlusion (pMCAO) was established via the suture method, followed by intravenous STVNa (7.5, 15, 30, 45, and 60 mg/kg). Neurobehavioral deficits, infarct volume, and histology were examined 24 hours after cerebral ischemia. In addition, the messenger RNA (mRNA) expression of NF-kappa B-related genes was detected using real-time quantitative polymerase chain reaction (qPCR). Results: STVNa (30 mg/kg) had significant neuroprotective effects 24 hours after pMCAO, including the reduction of the infarct volume and the improvement of the neurological severity score. Immunohistochemistry demonstrated that STVNa significantly increased the number of restored neurons and decreased the number of astrocytes. qPCR also demonstrated that the mRNA expression of inhibitor of nuclear factor kappa-B kinase-alpha, inhibitor of nuclear factor kappa-B kinase-beta, NF-kappa B, inhibitor of NF-kappa B-alpha, tumor necrosis factor-alpha, interleukin-1 beta, Bcl2-associated X protein, and caspase-3 were significantly downregulated, whereas B-cell CLL/lymphoma 2 mRNA was upregulated with STVNa treatment compared with vehicle. Conclusions: These findings demonstrate a neuroprotective role of STVNa during cerebral ischemia, which may result from interactions with the NF-kappa B signaling pathway and the associated inflammatory and apoptotic responses. (C) 2017 Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据